Bony orbital morphology in neurofibromatosis type 1 (NF1)

Journal of Medical Genetics

Volumn 35, Issue 8, 1998, Pages 628-631

  Kaste, Sue C ^a,b   Pivnick, Eniko K ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

MRI; Neurofibromatosis type 1; Orbital morphology

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MALFORMATION; CAUCASIAN; CHILD; EYE DEVELOPMENT; FEMALE; HUMAN; HYPERTELORISM; MAJOR CLINICAL STUDY; MALE; NEGRO; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPHENOID;

PIERINAE;

EID: 0031852102     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.35.8.628     Document Type: Article

References (25)

1. Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in South East Wales. Brain 1988;111:1355-81.
2. Burrows EH. Bone changes in orbital neurofibromatosis. Br J Radiol 1963;36:549-61.
3. Jacoby CG, Go RT, Beren RA. Cranial CT of neurofibromatosis. AJR 1980;135:553-7.
4. Hunt JC, Pugh DG. Skeletal lesions in neurofibromatosis. Radiology 1961;76:1-19.
5. Zimmerman RA, Bilaniuk LT, Metzger RA, Grossman RI, Schut L, Bruce DA. Computed tomography of orbital-facial neurofibromatosis. Radiology 1983;146:113-16.
6. Bognanno JR, Edwards MK, Lee TA, Dunn DW, Roos KL, Klatte EC. Cranial MR imaging in neurofibromatosis. AJR 1988;151:381-8.
7. Riccardi VM. Neurofibromatosis: phenotype, natural history and pathogenesis. 2nd ed. Baltimore: The John Hopkins University Press, 1992.
8. Rootman J, Robertson W. Tumors. In: Rotman J, ed. Disease of the orbit. New York: J B Lippincott, 1988.
9. Binet EF, Kieffer SA, Martin SH, Peterson HO. Orbital dysplasia in neurofibromatosis. Radiology 1969;93:829-33.
10. Moore RF. Diffuse neurofibromatosis with proptosis. Br J Ophthalmol 1993;15:272-9.
11. Le Wald LT. Congenital absence of the superior orbital wall associated with pulsating exophthalmos. AJR 1933;30:756-64.
12. Gardeur D, Palmieri A, Mashaly R. Cranial computed tomography in the phakomatoses. Neuroradiology 1983;25:293-304.
13. Murtaugh FR, Boyd RE, Okusski TA. Internal auditory canal flaring in neurofibromatosis without acoustic neuroma. Arch Neurol 1980;37:785.
14. DiMario FJ, Bowers P, Jagjivan B, Burleson J, Langshur S, Greenstein RM. Analysis of skull anthropometric measurements in patients with neurofibromatosis type-1. Invest Radiol 1992;28:116-20.
15. Westerhof W, Delleman JW, Wolters E, Dijkstra P. Neurofibromatosis and hypertelorism. Arch Dermatol 1984;120: 1579-81.
16. Wolters EC, Westerhof W, Delleman JW, Dijkstra P. Hypertelorism in neurofibromatosis. Neuropediatrics 1986;17: 175-7.
17. Waitzman AA, Posnick JC, Armstrong DC, et al. Craniofacial skeletal measurements based on computer tomography. Part II. Normal values and growth trends. Cleft Palate Craniofac J 1992;29:118-28.
18. Kennedy RE. The effect of early enucleation on the orbit in animals and humans. J Ophthalmol 1965;60:277-306.
19. Newton TH, Potts DG. Radiology of the skull and brain. Vol 1, book 2. St Louis: Mosby, 1971:465-9.
20. Saal HM, Schorry EK, Lovell AM, et al. Racial differences in the prevalence of optic nerve gliomas in neurofibromatosis type 1. Am J Hum Genet 1995;280:A54.
21. Pletcher B A, Magee MI, Frohman IP, et al. Conformation of decreased risk of optic glioma in African Americans with NF type I. Am J Hum Genet Suppl 1996;59:A101.
22. Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB. Orbital development in longterm survivors of retinoblastoma. J Clin Oncol 1997;15:1183-9.
23. Guyuron B, Dagys AP, Munro IR, et al. Effect of irradiation on facial growth: a 7- to 25-year follow-up. Ann Plastic Surg 1983;11:423-7.
24. Egawa S, Tsukiyama I, Akine Y, et al. Supression of bony growth of the orbit after radiotherapy for retinoblastoma. Radiat Med 1987;5:207-11.
25. Ju DMC, Moss M, Crikelair GF. Effect of radiation on the development of facial structures in retinoblastoma cases. Am J Surg 1963;106:807-15.